Title
White Market Drugs: Big Pharma And The Hidden History Of Addiction In America
Processing time: 1-3 days
US Orders Ships in: 3-5 days
International Orders Ships in: 8-12 days
Return Policy: 15-days return on defective items
Payment Option
The Contemporary Opioid Crisis Is Widely Seen As New And Unprecedented. Not So. It Is Merely The Latest In A Long Series Of Drug Crises Stretching Back Over A Century. In White Market Drugs, David Herzberg Explores These Crises And The Drugs That Fueled Them, From Bayers Heroin To Purdues Oxycontin And All The Drugs In Between: Barbiturate Goof Balls, Amphetamine Thrill Pills, The Love Drug Quaalude, And More. As Herzberg Argues, The Vast Majority Of American Experiences With Drugs And Addiction Have Taken Place Within What He Calls White Markets, Where Legal Drugs Called Medicines Are Sold To A Largely White Clientele.These Markets Are Widely Acknowledged But No One Has Explained How They Became So Central To The Medical System In A Nation Famous For Its Drug Warsuntil Now. Drawing From Federal, State, Industry, And Medical Archives Alongside A Wealth Of Published Sources, Herzberg Reconnects Americas Divided Drug History, Telling The Whole Story For The First Time. He Reveals That The Driving Question For Policymakers Has Never Been How To Prohibit The Use Of Addictive Drugs, But How To Ensure Their Availability In Medical Contexts, Where Profitability Often Outweighs Public Safety. Access To White Markets Was Thus A Doubleedged Sword For Socially Privileged Consumers, Even As Communities Of Color Faced Exclusion And Punitive Drug Prohibition. To Counter This Nowin Setup, Herzberg Advocates For A Consumer Protection Approach That Robustly Regulates All Drug Markets To Minimize Risks While Maintaining Safe, Reliable Access (And Treatment) For People With Addiction.Accomplishing This Requires Rethinking A Drug/Medicine Divide Born A Century Ago That, Unlike Most Policies Of That Racially Segregated Era, Has Somehow Survived Relatively Unscathed Into The Twentyfirst Century.By Showing How The Twentyfirstcentury Opioid Crisis Is Only The Most Recent In A Long History Of Similar Crises Of Addiction To Pharmaceuticals, Herzberg Forces Us To Rethink Our Most Basic Ideas About Drug Policy And Addiction Itselfideas That Have Been Failing Us Catastrophically For Over A Century.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.
- Q: What is the main topic of 'White Market Drugs'? A: 'White Market Drugs' explores the history of drug addiction in America, focusing on how legal drugs have contributed to various drug crises over the past century.
- Q: Who is the author of 'White Market Drugs'? A: The author of 'White Market Drugs' is David Herzberg.
- Q: When was 'White Market Drugs' published? A: 'White Market Drugs' was published on November 12, 2020.
- Q: What is the binding type of this book? A: 'White Market Drugs' is available in hardcover binding.
- Q: How many pages does 'White Market Drugs' have? A: 'White Market Drugs' contains 400 pages.
- Q: What edition of 'White Market Drugs' is available? A: The book is available in its first edition.
- Q: What are some key themes discussed in 'White Market Drugs'? A: Key themes include the evolution of drug policies, the societal impact of addiction, and the role of legal drug markets in America.
- Q: Does 'White Market Drugs' include historical case studies? A: Yes, the book includes historical case studies of various drugs, from heroin to OxyContin, and their impact on addiction.
- Q: Is 'White Market Drugs' suitable for academic study? A: Yes, 'White Market Drugs' is well-researched and suitable for academic study, particularly in the fields of history, sociology, and public health.
- Q: What perspective does Herzberg provide on drug policy? A: Herzberg advocates for a consumer protection approach to drug markets, emphasizing the need for regulation to ensure safety and access for those with addiction.